Device Wound Closure

Stratafix

Payments companies reported to CMS as associated with Stratafix. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4.8Massociated payments (2023-2025)

10,712clinicians with associated payments

9companies reporting

By year

2023 $1.5M

2024 $1.7M

2025 $1.6M

Payments reported as associated with Stratafix, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Physician Assistant $1.0M

Surgical $803K

Adult Reconstructive Orthopaedic Surgery $589K

Orthopaedic Surgery $542K

Surgery $312K

Obstetrics & Gynecology $241K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Stratafix

These are the largest totals companies reported as associated with Stratafix. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Michael Mont	Baltimore, MD	Adult Reconstructive Orthopaedic Surgery	$223,176.56
Jeanine Gargiulo	Alexandria, VA	Surgical	$205,984.07
Steven Wurzelbacher	Cincinnati, OH	Physician Assistant	$184,266.95
Antonia Chen	Dallas, TX	Adult Reconstructive Orthopaedic Surgery	$166,958.22
Jefferson Morrison	Nashville, TN	Orthopaedic Surgery	$157,209.70
Heather Austin	Salinas, CA	Physician Assistant	$144,736.53
Michael Berke	Atlanta, GA	Surgical	$144,397.09
Sean Rajaee	West Hollywood, CA	Orthopaedic Surgery	$117,310.16
Joshua Beardsley	Rock Hill, SC	Surgical	$112,600.74
Michael Wang	Miami, FL	Neurological Surgery	$101,277.43

Prescribed Stratafix?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.